[{"NetIncomeLoss_1_Q1_USD":-17457000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"ShareBasedCompensation_1_Q1_USD":2793000.0,"UnrealizedGainLossOnInvestments_1_Q1_USD":-31000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-31000.0,"Assets_0_Q1_USD":386365000.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_1_Q1_USD":0.0,"CommonStockSharesIssued_0_Q1_shares":43477439.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":7261364.0,"AssetsCurrent_0_Q1_USD":251172000.0,"PaymentsToAcquireInvestments_1_Q1_USD":169627000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-169631000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-40000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":4581000.0,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":-58000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":182389000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-17488000.0,"FairValueConcentrationOfRiskInvestments_0_Q1_USD":0.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":0.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_1_Q1_USD":-183073000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":31000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":489000.0,"CommonStockValue_0_Q1_USD":4000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-379000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":43477439.0,"EarningsPerShareBasic_1_Q1_USD":-0.4,"ResearchAndDevelopmentExpense_1_Q1_USD":12666000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":4815000.0,"ShortTermInvestments_0_Q1_USD":65808000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-368000.0,"OperatingIncomeLoss_1_Q1_USD":-17481000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":283000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":0.0,"AdditionalPaidInCapital_0_Q1_USD":449394000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":142000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":2975000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":182389000.0,"NonoperatingIncomeExpense_1_Q1_USD":24000.0,"AccountsPayableCurrent_0_Q1_USD":3212000.0,"LiabilitiesCurrent_0_Q1_USD":7793000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":43477439.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-13442000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2793000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":87000.0,"CommonStockSharesAuthorized_0_Q1_shares":1000000000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.4,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-70786000.0,"ManagementFeeExpense_1_Q1_USD":0.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-276000.0,"LongTermInvestments_0_Q1_USD":134910000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":4000.0,"StockholdersEquity_0_Q1_USD":378572000.0,"OperatingExpenses_1_Q1_USD":17481000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":370000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2800000.0,"PreferredStockSharesAuthorized_0_Q1_shares":200000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":896000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":386365000.0,"PreferredStockValue_0_Q1_USD":0.0,"InvestmentIncomeInterest_1_Q1_USD":403000.0,"CommonStockSharesOutstanding_0_Q1_shares":43477439.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":237000.0,"Ticker":"KNTE","CIK":"1797768","name":"KINNATE BIOPHARMA INC.","OfficialName":"Kinnate Biopharma Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"393785585.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210517"}]